Najeeb Ali is a founding member of the MedTech practice at Centerview Partners. He has 20 years of experience as a strategic advisor to healthcare companies across medical device, life sciences/diagnostics, services, and specialty pharma sectors. Over the course of his career, Mr. Ali has engaged with clients on a broad range of complex strategic transactions, spin-offs and carve-outs, buy-side and sell-side mergers and acquisitions, divestitures, special committee assignments, activism, debt and equity financings, and partnerships.

Select experience includes:

Medical Device and Life Sciences / Diagnostics

Teleflex on its $2.03 billion sale of Acute Care, Interventional Urology, and OEM businesses to Intersurgical, Montagu and Kohlberg; advisor to Teleflex on its intent to separate into 2 businesses; advisor to Teleflex on its $600 million acquisition of Palette Life Sciences

Sebia on the sale of significant minority stake to Warburg Pincus

Foresight on its $450 million sale to Natera

ZimVie on its ~$750 million sale to Archimed; advisor to ZimVie on the $375 million sale of its spine business to HIG Capital

Masimo on its $350 million sale of Sound United consumer audio business to Samsung; Special Committee of the Board of Masimo in connection with its evaluation of certain strategic alternatives

Illumina on 85.5% Spin-off of Grail; advisor to Illumina on its settlement with Corvex Management; and advisor to Illumina on its proxy fight with Carl Icahn

Bolt Medical on its ~$900 million sale to Boston Scientific

Azenta on its settlement with Politan Capital

BK Medical on its $1.5 billion sale to GE

Wright Medical on its $5.4 billion sale to Stryker

Zimmer Biomet on its Spin-off of ZimVie

Danaher on its carve-out IPO and Split-off of Envista

Cardinal Health on its $1.0 billion sale of Cordis business to Hellman & Friedman 

Envista on its $600 million acquisition of Carestream Dental’s intra-oral scanner business from Clayton, Dubilier & Rice and on $455 million sale of its KaVo business to Planmeca

Enovis (formerly Colfax) on its $3.2 billion acquisition of DJO Global from Blackstone

Covidien on its Spin-off of Mallinckrodt

Healthcare Services

Cardinal Health on its $3.9 billion acquisition of majority stake in GI Alliance

Blackstone, Carlyle, and Hellman & Friedman on its $34 billion acquisition of Medline Industries

PharMEDium on its $2.6 billion sale to AmerisourceBergen

Specialty Pharma

Amneal on its $6.4 billion merger with Impax Labs

Altaris Capital on its $1.6 billion acquisition of Padagis, formerly Perrigo’s generic prescription pharmaceuticals division

Par Pharmaceuticals on its $1.9 billion sale to TPG and subsequent $8.1 billion sale to Endo International

Gavis Pharmaceuticals on its $900 million sale to Lupin

Prior to joining Centerview in 2022, Mr. Ali spent 18 years at J.P. Morgan, most recently as a Managing Director within its Healthcare business. Mr. Ali received his Bachelor of Science and a Master of Business Administration in Finance from Kelley School of Business at Indiana University Bloomington.